Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP).
Manzanedo I, Pereira F, Cascales-Campos P, Muñoz-Casares C, Asensio E, Torres-Melero J, Prada-Villaverde A, Caravaca-García I, Gutiérrez-Calvo A, Vaqué J, Ortega G, Titos-García A, González-Sánchez L, Pérez-Viejo E, Serrano Á, Martínez-Torres B, Regecop Group. Manzanedo I, et al. Among authors: cascales campos p. J Clin Med. 2023 May 31;12(11):3774. doi: 10.3390/jcm12113774. J Clin Med. 2023. PMID: 37297969 Free PMC article.
Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study.
Cascales-Campos PA, López-López V, Muñoz-Casares FC, Feliciangeli E, Torres Melero J, Barrios P, Morales R, Ramos I, Ortega G, Camps B, González-Bayón L, Bretcha-Boix P, Farré-Alegre J, González-Moreno S, Gil J. Cascales-Campos PA, et al. Surg Oncol. 2016 Jun;25(2):111-6. doi: 10.1016/j.suronc.2016.03.007. Epub 2016 Apr 4. Surg Oncol. 2016. PMID: 27312037
Effectiveness and failures of a fast track protocol after cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy in patients with peritoneal surface malignancies.
Cascales-Campos PA, Sánchez-Fuentes PA, Gil J, Gil E, López-López V, Rodriguez Gomez-Hidalgo N, Fuentes D, Parrilla P. Cascales-Campos PA, et al. Surg Oncol. 2016 Dec;25(4):349-354. doi: 10.1016/j.suronc.2016.08.001. Epub 2016 Aug 13. Surg Oncol. 2016. PMID: 27916165 Review.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?
López-López V, Cascales-Campos PA, Gil E, Arevalo J, Gonzalez A, Gil J, Muñoz-Casares FC, Melero JT, Barrios P, Morales R, Ramos I, Ortega G, Camps B, González-Bayón L, Bretcha-Boix P, Farré-Alegre J, González-Moreno S, Parrilla P. López-López V, et al. Clin Transl Oncol. 2017 Nov;19(11):1388-1392. doi: 10.1007/s12094-017-1728-9. Epub 2017 Aug 10. Clin Transl Oncol. 2017. PMID: 28812240
Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP).
Cascales-Campos PA, López-López V, Torres-Melero J, Arjona A, Muñoz-Casares FC, Barrios P, Morales R, Pereira F, Bretcha-Boix P, González-Bayón L, González-Moreno S, Gil J. Cascales-Campos PA, et al. Clin Transl Oncol. 2020 Jan;22(1):130-136. doi: 10.1007/s12094-019-02124-9. Epub 2019 May 2. Clin Transl Oncol. 2020. PMID: 31049819
Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies.
Cascales Campos PA, González-Gil A, Gómez-Ruiz AJ, Gil-Gómez E, Alconchel-Gago F, Navarro-Barrios A, Martínez-García J, Alonso-Romero JL, Nieto A, Barceló-Valcarcel F, Gil-Martínez J. Cascales Campos PA, et al. Hernia. 2020 Apr;24(2):257-263. doi: 10.1007/s10029-019-01962-4. Epub 2019 May 8. Hernia. 2020. PMID: 31069579 Clinical Trial.
RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score.
Arjona-Sanchez A, Rodriguez-Ortiz L, Baratti D, Schneider MA, Gutiérrez-Calvo A, García-Fadrique A, Tuynman JB, Cascales-Campos PA, Martín VC, Morales R, Salti GI, Arteaga X, Pacheco D, Alonso-Gomez J, Yalkin O, Villarejo-Campos P, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Rufian-Peña S, Briceño J. Arjona-Sanchez A, et al. Ann Surg Oncol. 2019 Aug;26(8):2595-2604. doi: 10.1245/s10434-019-07378-9. Epub 2019 May 20. Ann Surg Oncol. 2019. PMID: 31111351
75 results